Cleared Traditional

AQUAbase nX

K223479 · B.Braun Medical, Inc. · Gastroenterology & Urology
Aug 2023
Decision
271d
Days
Class 2
Risk

About This 510(k) Submission

K223479 is an FDA 510(k) clearance for the AQUAbase nX, a Subsystem, Water Purification (Class II — Special Controls, product code FIP), submitted by B.Braun Medical, Inc. (Allentown, US). The FDA issued a Cleared decision on August 16, 2023, 271 days after receiving the submission on November 18, 2022. This device falls under the Gastroenterology & Urology review panel. Regulated under 21 CFR 876.5665.

Submission Details

510(k) Number K223479 FDA.gov
FDA Decision Cleared SESE
Date Received November 18, 2022
Decision Date August 16, 2023
Days to Decision 271 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF

Device Classification

Product Code FIP — Subsystem, Water Purification
Device Class Class II — Special Controls
CFR Regulation 21 CFR 876.5665

Similar Devices — FIP Subsystem, Water Purification

All 116
AquaC UNO H
K250471 · Fresenius Medical Care Renal Therapies Group, LLC · Nov 2025
DIASAFEplusUS (F00013010)
K251851 · Fresenius Medical Care Renal Therapies Group, LLC · Oct 2025
AquaA
K252181 · Fresenius Medical Care North America · Sep 2025
UPT Series Medical RO Water Treatment System
K250514 · Specialty Water Technologies, Inc. · Mar 2025
AquaBplus; AquaB LITE
K232953 · Fresenius Medical Care Renal Therapies Group, LLC · Jun 2024
RenaPure Endotoxin Retentive Filter
K231410 · Evoqua Water Technologies, LLC · Jul 2023